| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | NVDA | United States | $171.66 | $215,938,000,000.00 | Strong Buy | 38 | 1998 |
#2 | AAPL | United States | $253.05 | $265,595,000,000.00 | Buy | 28 | 1994 |
#3 | AMZN | United States | $207.59 | $716,924,000,000.00 | Strong Buy | 45 | 1997 |
#4 | TSM | Taiwan | $326.54 | $0.00 | Buy | 6 | N/A |
#5 | WMT | United States | $122.18 | $713,163,000,000.00 | Strong Buy | 31 | 2011 |
#6 | JPM | United States | $291.51 | $0.00 | Buy | 13 | N/A |
#7 | V | United States | $305.76 | $21,846,000,000.00 | Strong Buy | 20 | 2007 |
#8 | XOM | United States | $165.44 | $332,238,000,000.00 | Buy | 21 | 2005 |
#9 | JNJ | United States | $239.28 | $0.00 | Buy | 19 | 2003 |
#10 | MA | United States | $501.24 | $32,791,000,000.00 | Strong Buy | 24 | 2005 |
#11 | COST | United States | $979.73 | $275,235,000,000.00 | Buy | 21 | 1994 |
#12 | BAC | United States | $48.16 | $0.00 | Buy | 19 | N/A |
#13 | ASML | Netherlands | $1,329.12 | $0.00 | Buy | 10 | N/A |
#14 | ABBV | United States | $211.39 | $61,160,000,000.00 | Buy | 20 | 2012 |
#15 | CVX | United States | $207.52 | $189,031,000,000.00 | Buy | 19 | 1994 |
#16 | HD | United States | $327.97 | $66,176,000,000.00 | Buy | 23 | 1996 |
#17 | BABA | Hong Kong | $125.30 | $0.00 | Strong Buy | 13 | N/A |
#18 | AMD | United States | $204.02 | $0.00 | Buy | 34 | 2002 |
#19 | KO | United States | $74.73 | $47,941,000,000.00 | Strong Buy | 13 | 2003 |
#20 | GE | United States | $285.88 | $45,855,000,000.00 | Strong Buy | 10 | 2008 |
#21 | CAT | United States | $701.14 | $67,589,000,000.00 | Buy | 19 | 2009 |
#22 | CSCO | United States | $82.21 | $49,330,000,000.00 | Buy | 16 | 2002 |
#23 | WFC | United States | $78.85 | $0.00 | Buy | 16 | N/A |
#24 | PM | United States | $162.55 | $40,648,000,000.00 | Strong Buy | 9 | 2007 |
#25 | AMAT | United States | $338.41 | $14,608,000,000.00 | Buy | 28 | 1994 |
#26 | MRK | United States | $118.97 | $65,011,000,000.00 | Buy | 14 | 1994 |
#27 | MS | United States | $163.25 | $0.00 | Buy | 14 | N/A |
#28 | SHEL | United Kingdom | $92.18 | $0.00 | Buy | 8 | N/A |
#29 | TMUS | United States | $211.44 | $40,604,000,000.00 | Buy | 18 | 2004 |
#30 | MCD | United States | $309.31 | $26,885,000,000.00 | Buy | 28 | 1995 |
#31 | LIN | United Kingdom | $495.59 | $33,986,000,000.00 | Strong Buy | 9 | 2017 |
#32 | PEP | United States | $150.84 | $93,925,000,000.00 | Buy | 13 | 1995 |
#33 | VZ | United States | $50.65 | $138,191,000,000.00 | Buy | 16 | 2018 |
#34 | C | United States | $112.21 | $0.00 | Buy | 14 | N/A |
#35 | NEE | United States | $91.14 | $0.00 | Buy | 13 | N/A |
#36 | TTE | France | $90.08 | $0.00 | Buy | 7 | N/A |
#37 | KLAC | United States | $1,450.49 | $0.00 | Buy | 19 | 1994 |
#38 | GILD | United States | $136.83 | $24,689,000,000.00 | Strong Buy | 18 | 2001 |
#39 | TMO | United States | $488.86 | $20,918,000,000.00 | Strong Buy | 19 | 1996 |
#40 | ADI | United States | $313.48 | $6,200,942,000.00 | Buy | 22 | 1994 |
#41 | DE | United States | $580.96 | $45,684,000,000.00 | Buy | 18 | 1994 |
#42 | TJX | United States | $157.61 | $29,078,407,000.00 | Strong Buy | 16 | 1994 |
#43 | BA | United States | $194.77 | $89,463,000,000.00 | Strong Buy | 19 | 2005 |
#44 | SCHW | United States | $94.50 | $0.00 | Buy | 16 | N/A |
#45 | T | United States | $28.87 | $0.00 | Buy | 20 | N/A |
#46 | BLK | United States | $969.90 | $12,794,000,000.00 | Strong Buy | 15 | 2024 |
#47 | TXN | United States | $193.19 | $17,682,000,000.00 | Buy | 24 | 2000 |
#48 | UNP | United States | $239.02 | $19,533,000,000.00 | Buy | 23 | 2004 |
#49 | LOW | United States | $236.03 | $86,286,000,000.00 | Buy | 22 | 1994 |
#50 | PDD | Ireland | $100.80 | $0.00 | Buy | 9 | 2018 |
The FinQuota filters have identified what they believe to be the "Best Uptrend Stocks to Buy (March 27, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.